Literature DB >> 34616229

Gene polymorphism of 3'APO-VNTR in Egyptians with coronary artery disease.

Rehab Elmougy1.   

Abstract

BACKGROUND: Coronary artery diseases (CAD) are big health problem in both developed and developing countries. It is considered one of the main causes of death in the world. Dyslipidemia increases the risk of CAD incidences. It is aimed in this worktop study the impact of 3'APOBVNTRgene on CAD incidences.
METHODS: Eighty CAD patients and ninety-three healthy volunteers are enrolled in this study. Lipid parameters were estimated in both groups and PCR technique has been performed to analyze 3'APOB-VNTR gene polymorphism.
RESULTS: The genotypes 31/31, 31/37, 37/37 and 31/44 are more predominant in both groups. The frequency of 24/31 in CAD patients is (0.137) while it is completely absent in the control group. Our results show that there is an increase in the frequency of various genotypes (e.g., 17/31 and 21/34 genotypes) in the control group compared to theca patients group.
CONCLUSIONS: 3'APOB-VNTR gene could probably be considered a risk factor for CAD incidences and may help to early diagnose them. 2021 Rehab Elmougy, published by CEON/CEES.

Entities:  

Keywords:  Apo B; PCR; coronary artery disease; dyslipidemia; genetics

Year:  2021        PMID: 34616229      PMCID: PMC8451227          DOI: 10.5937/jomb0-30616

Source DB:  PubMed          Journal:  J Med Biochem        ISSN: 1452-8266            Impact factor:   3.402


  20 in total

1.  Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats.

Authors:  Sevim Tunali; Refiye Yanardag
Journal:  Pharmacol Res       Date:  2006-01-20       Impact factor: 7.658

2.  Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.

Authors:  Marianne Benn; Børge G Nordestgaard; Gorm Boje Jensen; Anne Tybjaerg-Hansen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-14       Impact factor: 8.311

3.  The 4-hydroxybenzoate/4-aminophenazone chromogenic system used in the enzymic determination of serum cholesterol.

Authors:  F Meiattini; L Prencipe; F Bardelli; G Giannini; P Tarli
Journal:  Clin Chem       Date:  1978-12       Impact factor: 8.327

4.  Serum lipid abnormalities are not associated with apoB 3' VNTR polymorphism in nephrotic children.

Authors:  P Hu; B Hu; Y H Qin; L Lu; Z Q Li; L Q Tao; Q Pei; J Chen
Journal:  Genet Mol Res       Date:  2013-03-13

Review 5.  Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review.

Authors:  Marianne Benn
Journal:  Atherosclerosis       Date:  2009-01-15       Impact factor: 5.162

6.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

7.  Association between apolipoprotein B genetic polymorphism and the risk of calcific aortic stenosis in Chinese subjects, in Xinjiang, China.

Authors:  Yong-Tao Wang; Yang Li; Yi-Tong Ma; Yi-Ning Yang; Xiang Ma; Xiao-Mei Li; Fen Liu; Bang-Dang Chen
Journal:  Lipids Health Dis       Date:  2018-03-07       Impact factor: 3.876

8.  Predicting coronary artery disease: a comparison between two data mining algorithms.

Authors:  Haleh Ayatollahi; Leila Gholamhosseini; Masoud Salehi
Journal:  BMC Public Health       Date:  2019-04-29       Impact factor: 3.295

Review 9.  Lipoproteins as targets and markers of lipoxidation.

Authors:  Catarina B Afonso; Corinne M Spickett
Journal:  Redox Biol       Date:  2018-12-06       Impact factor: 11.799

10.  The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects.

Authors:  Saleem Ullah Shahid; Sumbal Sarwar
Journal:  Lipids Health Dis       Date:  2020-04-14       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.